BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 33842548)

  • 1. The Dose-Dependent Pleiotropic Effects of the UBB
    Banasiak K; Szulc NA; Pokrzywa W
    Front Mol Biosci; 2021; 8():650730. PubMed ID: 33842548
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disease-associated mutant ubiquitin causes proteasomal impairment and enhances the toxicity of protein aggregates.
    Tank EM; True HL
    PLoS Genet; 2009 Feb; 5(2):e1000382. PubMed ID: 19214209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different Expression Levels of Human Mutant Ubiquitin B
    Muñoz-Arellano AJ; Chen X; Molt A; Meza E; Petranovic D
    Front Mol Neurosci; 2018; 11():200. PubMed ID: 29950972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose-dependent inhibition of proteasome activity by a mutant ubiquitin associated with neurodegenerative disease.
    van Tijn P; de Vrij FM; Schuurman KG; Dantuma NP; Fischer DF; van Leeuwen FW; Hol EM
    J Cell Sci; 2007 May; 120(Pt 9):1615-23. PubMed ID: 17405812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term proteasomal inhibition in transgenic mice by UBB(+1) expression results in dysfunction of central respiration control reminiscent of brainstem neuropathology in Alzheimer patients.
    Irmler M; Gentier RJ; Dennissen FJ; Schulz H; Bolle I; Hölter SM; Kallnik M; Cheng JJ; Klingenspor M; Rozman J; Ehrhardt N; Hermes DJ; Gailus-Durner V; Fuchs H; Hrabě de Angelis M; Meyer HE; Hopkins DA; Van Leeuwen FW; Beckers J
    Acta Neuropathol; 2012 Aug; 124(2):187-97. PubMed ID: 22730000
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low levels of mutant ubiquitin are degraded by the proteasome in vivo.
    van Tijn P; Verhage MC; Hobo B; van Leeuwen FW; Fischer DF
    J Neurosci Res; 2010 Aug; 88(11):2325-37. PubMed ID: 20336771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Localization of mutant ubiquitin in the brain of a transgenic mouse line with proteasomal inhibition and its validation at specific sites in Alzheimer's disease.
    Gentier RJ; Verheijen BM; Zamboni M; Stroeken MM; Hermes DJ; Küsters B; Steinbusch HW; Hopkins DA; Van Leeuwen FW
    Front Neuroanat; 2015; 9():26. PubMed ID: 25852488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. UBB
    Chen X; Muñoz-Arellano AJ; Petranovic D
    Aging (Albany NY); 2021 Nov; 13(21):23953-23980. PubMed ID: 34751669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frameshift proteins in Alzheimer's disease and in other conformational disorders: time for the ubiquitin-proteasome system.
    van Leeuwen FW; Hol EM; Fischer DF
    J Alzheimers Dis; 2006; 9(3 Suppl):319-25. PubMed ID: 16914870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular misreading: the occurrence of frameshift proteins in different diseases.
    van Leeuwen FW; Kros JM; Kamphorst W; van Schravendijk C; de Vos RA
    Biochem Soc Trans; 2006 Nov; 34(Pt 5):738-42. PubMed ID: 17052186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review: unchained maladie - a reassessment of the role of Ubb(+1) -capped polyubiquitin chains in Alzheimer's disease.
    Chadwick L; Gentle L; Strachan J; Layfield R
    Neuropathol Appl Neurobiol; 2012 Apr; 38(2):118-31. PubMed ID: 22082077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alzheimer's disease-associated ubiquitin mutant Ubb
    Munari F; Bortot A; Assfalg M; D'Onofrio M
    Int J Biol Macromol; 2018 Mar; 108():24-31. PubMed ID: 29175520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Accumulation of Basic Amino Acids at Mitochondria Dictates the Cytotoxicity of Aberrant Ubiquitin.
    Braun RJ; Sommer C; Leibiger C; Gentier RJG; Dumit VI; Paduch K; Eisenberg T; Habernig L; Trausinger G; Magnes C; Pieber T; Sinner F; Dengjel J; van Leeuwen FW; Kroemer G; Madeo F
    Cell Rep; 2015 Mar; 10(9):1557-1571. PubMed ID: 25753421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disease-specific accumulation of mutant ubiquitin as a marker for proteasomal dysfunction in the brain.
    Fischer DF; De Vos RA; Van Dijk R; De Vrij FM; Proper EA; Sonnemans MA; Verhage MC; Sluijs JA; Hobo B; Zouambia M; Steur EN; Kamphorst W; Hol EM; Van Leeuwen FW
    FASEB J; 2003 Nov; 17(14):2014-24. PubMed ID: 14597671
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutant ubiquitin decreases amyloid β plaque formation in a transgenic mouse model of Alzheimer's disease.
    van Tijn P; Dennissen FJ; Gentier RJ; Hobo B; Hermes D; Steinbusch HW; Van Leeuwen FW; Fischer DF
    Neurochem Int; 2012 Oct; 61(5):739-48. PubMed ID: 22797007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutant ubiquitin UBB+1 induces mitochondrial fusion by destabilizing mitochondrial fission-specific proteins and confers resistance to oxidative stress-induced cell death in astrocytic cells.
    Yim N; Ryu SW; Han EC; Yoon J; Choi K; Choi C
    PLoS One; 2014; 9(6):e99937. PubMed ID: 24941066
    [TBL] [Abstract][Full Text] [Related]  

  • 17. +1 Proteins and aging.
    van Leeuwen FW; Gerez L; Benne R; Hol EM
    Int J Biochem Cell Biol; 2002 Nov; 34(11):1502-5. PubMed ID: 12200043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alzheimer's disease-associated mutant ubiquitin (UBB
    Wagh AR; Sulakshane P; Glickman MH
    Biochim Biophys Acta Gene Regul Mech; 2023 Jun; 1866(2):194936. PubMed ID: 37075976
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of frameshift ubiquitin B protein in Alzheimer's disease.
    Chen X; Petranovic D
    Wiley Interdiscip Rev Syst Biol Med; 2016 Jul; 8(4):300-13. PubMed ID: 27240056
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Molecular Misreading of APP and UBB Induces a Humoral Immune Response in Alzheimer's Disease Patients with Diagnostic Ability.
    Montero-Calle A; San Segundo-Acosta P; Garranzo-Asensio M; Rábano A; Barderas R
    Mol Neurobiol; 2020 Feb; 57(2):1009-1020. PubMed ID: 31654319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.